KRTAP6-1

gene
On this page

Also known as KAP6.1C21orf103

Summary

KRTAP6-1 (keratin associated protein 6-1, HGNC:18931) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 6-1 (Q3LI64). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….

Predicted to be involved in keratinization. Located in cytosol.

Source: NCBI Gene 337966 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 15 total
  • MANE Select transcript: NM_181602

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18931
Approved symbolKRTAP6-1
Namekeratin associated protein 6-1
Location21q22.11
Locus typegene with protein product
StatusApproved
AliasesKAP6.1, C21orf103
Ensembl geneENSG00000184724
Ensembl biotypeprotein_coding
Entrez337966

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000329122

RefSeq mRNA: 1 — MANE Select: NM_181602 NM_181602

CCDS: CCDS13602

Canonical transcript exons

ENST00000329122 — 1 exons

ExonStartEnd
ENSE000015405383061343130613930

Expression profiles

Bgee: expression breadth broad, 12 present calls, max score 37.47.

Top tissues by expression

120 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
sural nerveUBERON:001548837.47gold quality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
skeletal muscle tissueUBERON:000113435.73gold quality
ganglionic eminenceUBERON:000402335.49gold quality
muscle tissueUBERON:000238532.79gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
bone marrowUBERON:000237131.74gold quality
stromal cell of endometriumCL:000225529.87gold quality
prefrontal cortexUBERON:000045129.50silver quality
primary visual cortexUBERON:000243629.16silver quality
duodenumUBERON:000211428.14gold quality
liverUBERON:000210728.04gold quality
lymph nodeUBERON:000002927.57gold quality
skin of abdomenUBERON:000141627.16gold quality
tonsilUBERON:000237227.05gold quality
leukocyteCL:000073826.85gold quality
monocyteCL:000057626.78gold quality
islet of LangerhansUBERON:000000626.55gold quality
vermiform appendixUBERON:000115426.42gold quality
bloodUBERON:000017826.10gold quality
gall bladderUBERON:000211025.98gold quality
olfactory segment of nasal mucosaUBERON:000538625.89gold quality
placentaUBERON:000198725.81gold quality
urinary bladderUBERON:000125525.72gold quality
zone of skinUBERON:000001425.59gold quality
muscle of legUBERON:000138325.02gold quality
skin of legUBERON:000151124.31gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.98

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • Expressed and purified are a high sulfur KAP (KAP11.1) and a high glycine-tyrosine KAP (KAP6.1). (PMID:29391282)

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Keratin-associated protein 6-1Q3LI64 (reviewed: Q3LI64)

All UniProt accessions (1): Q3LI64

UniProt curated annotations — full annotation on UniProt →

Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.

Subunit / interactions. Interacts with hair keratins.

Similarity. Belongs to the KRTAP type 6 family.

RefSeq proteins (1): NP_853633* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR040313KAP6Family

UniProt features (1 total): chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q3LI64-F143.850.00

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-6805567Keratinization
R-HSA-1266738Developmental Biology

MSigDB gene sets: 38 (showing top): GOBP_EPITHELIUM_DEVELOPMENT, DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, DARWICHE_PAPILLOMA_PROGRESSION_RISK, GGGTGGRR_PAX4_03, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, HOWLIN_PUBERTAL_MAMMARY_GLAND, MARTINEZ_RB1_TARGETS_DN, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6, GOBP_EPIDERMIS_DEVELOPMENT, POU3F2_02, GOBP_KERATINIZATION, chr21q22

GO Biological Process (1): keratinization (GO:0031424)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Developmental Biology1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
keratinocyte differentiation1
multicellular organismal process1
binding1
cytoplasm1
cellular anatomical structure1
intermediate filament cytoskeleton1
polymeric cytoskeletal fiber1

Protein interactions and networks

STRING

186 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KRTAP6-1KRTAP22-1Q3MIV0877
KRTAP6-1KRTAP6-3Q3LI67870
KRTAP6-1KRTAP20-1Q3LI63791
KRTAP6-1KRTAP6-2Q3LI66791
KRTAP6-1KRTAP20-2Q3LI61782
KRTAP6-1KRTAP26-1Q6PEX3769
KRTAP6-1KRTAP8-1Q8IUC2767
KRTAP6-1KRTAP24-1Q3LI83723
KRTAP6-1SCYGR1A0A286YEY9720
KRTAP6-1KRTAP15-1Q3LI76720
KRTAP6-1KRTAP7-1Q8IUC3701
KRTAP6-1KRTAP13-3Q3SY46690
KRTAP6-1A8MUN0A8MUN0669
KRTAP6-1KRTAP11-1Q8IUC1659
KRTAP6-1KRTAP1-1Q07627626

IntAct

293 interactions, top by confidence:

ABTypeScore
TRIP13KRTAP6-1psi-mi:“MI:0915”(physical association)0.600
GLIS3KRTAP6-1psi-mi:“MI:0915”(physical association)0.560
VENTXKRTAP6-1psi-mi:“MI:0915”(physical association)0.560
HOXC8KRTAP6-1psi-mi:“MI:0915”(physical association)0.560
NOTOKRTAP6-1psi-mi:“MI:0915”(physical association)0.560
MAGED1KRTAP6-1psi-mi:“MI:0915”(physical association)0.560
CCDC24KRTAP6-1psi-mi:“MI:0915”(physical association)0.560
MED25KRTAP6-1psi-mi:“MI:0915”(physical association)0.560
TENT5BKRTAP6-1psi-mi:“MI:0915”(physical association)0.560
CATSPER1KRTAP6-1psi-mi:“MI:0915”(physical association)0.560
KRTAP6-1KRTAP12-3psi-mi:“MI:0915”(physical association)0.560
KPRPKRTAP6-1psi-mi:“MI:0915”(physical association)0.560
GPS2KRTAP6-1psi-mi:“MI:0915”(physical association)0.560
MAPK1IP1LKRTAP6-1psi-mi:“MI:0915”(physical association)0.560
CRYABKRTAP6-1psi-mi:“MI:0915”(physical association)0.560
CAMK2GKRTAP6-1psi-mi:“MI:0915”(physical association)0.560
KRTAP6-1CAMK2Apsi-mi:“MI:0915”(physical association)0.560
TNIP1KRTAP6-1psi-mi:“MI:0915”(physical association)0.560
VAC14KRTAP6-1psi-mi:“MI:0915”(physical association)0.560
CYSRT1KRTAP6-1psi-mi:“MI:0915”(physical association)0.560
DAZAP2KRTAP6-1psi-mi:“MI:0915”(physical association)0.560
KRTAP6-1ITIH6psi-mi:“MI:0915”(physical association)0.560
KRTAP6-1GLIS2psi-mi:“MI:0915”(physical association)0.560

BioGRID (103): KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid)

ESM2 similar proteins: H2A0M6, O08632, O08633, O08640, P02448, P04459, P05685, P08826, P25692, P82170, P83358, Q02957, Q02958, Q28580, Q3LHN2, Q3LI54, Q3LI58, Q3LI59, Q3LI60, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI68, Q3LI70, Q3LI72, Q3LI73, Q3LI77, Q3MIV0, Q3SYF9, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q6F4C6, Q6R645, Q7Z4W3, Q8C1I6

Diamond homologs: Q3LI64, Q3LI66, Q3LI67, Q925H3

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 87 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization89.5×4e-04

GO biological processes:

GO termPartnersFoldFDR
anterior/posterior pattern specification614.5×5e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

15 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance15
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

170 predictions. Top by Δscore:

VariantEffectΔscore
21:30613884:T:Adonor_gain0.8000
21:30613860:ATAG:Adonor_gain0.7900
21:30613903:A:Cdonor_gain0.7900
21:30613880:AGTTT:Adonor_gain0.7800
21:30613893:G:Cdonor_gain0.7800
21:30613895:TGCCA:Tdonor_gain0.7600
21:30613878:G:Cdonor_gain0.7500
21:30613863:G:Cdonor_gain0.7100
21:30613897:C:CTdonor_gain0.7000
21:30613862:AG:Adonor_gain0.6900
21:30613877:A:ACdonor_gain0.6900
21:30613755:G:Cdonor_gain0.6700
21:30613872:G:Adonor_gain0.6700
21:30613724:AG:Adonor_gain0.6600
21:30613855:A:Tdonor_gain0.6600
21:30613899:A:Tdonor_gain0.6600
21:30613581:T:TAdonor_gain0.6500
21:30613837:AGG:Adonor_gain0.6500
21:30613895:TGC:Tdonor_gain0.6500
21:30613686:T:TAdonor_gain0.6400
21:30613853:A:ACdonor_gain0.6400
21:30613858:C:CTdonor_gain0.6400
21:30613754:AG:Adonor_gain0.6300
21:30613821:T:TAdonor_gain0.6300
21:30613826:AG:Adonor_gain0.6100
21:30613925:T:TAdonor_gain0.6100
21:30613842:T:TAdonor_gain0.6000
21:30613827:G:Cdonor_gain0.5900
21:30613847:AG:Adonor_gain0.5900
21:30613852:CA:Cdonor_gain0.5800

AlphaMissense

430 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
21:30613779:G:CF42L0.857
21:30613779:G:TF42L0.857
21:30613781:A:GF42L0.857
21:30613769:C:GG46R0.664
21:30613763:C:GG48R0.603
21:30613893:G:CS4R0.602
21:30613893:G:TS4R0.602
21:30613895:T:GS4R0.602
21:30613901:A:GC2R0.602
21:30613899:A:CC2W0.592
21:30613756:C:TG50D0.566
21:30613762:C:TG48D0.565

dbSNP variants (sampled 300 via entrez): RS1001092125 (21:30615888 A>T), RS1002741151 (21:30615841 G>A), RS1002874265 (21:30613998 G>A,T), RS1003494580 (21:30613011 T>C), RS1004373699 (21:30613921 G>A), RS1006093814 (21:30615170 G>A), RS1006454122 (21:30615430 G>A,C), RS1008436894 (21:30615321 G>A), RS1009015718 (21:30615593 C>T), RS1010535796 (21:30613384 C>T), RS1011048021 (21:30614755 A>G), RS1011639356 (21:30613147 T>A,G), RS1013293883 (21:30614881 T>C), RS1017415412 (21:30615190 A>G), RS1018494598 (21:30613506 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
CGP 52608affects binding, increases reaction1
Resveratrolaffects cotreatment, decreases expression1
Atrazineincreases expression1
Phthalic Acidsincreases methylation1
Plant Extractsdecreases expression, affects cotreatment1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.